Article Details

Chinese biotech becomes ok for Philippines' mRNA COVID-19 omicron experiment

Retrieved on: 2022-06-27 16:12:35

Tags for this article:

Click the tags to see associated articles and topics

Chinese biotech becomes ok for Philippines' mRNA COVID-19 omicron experiment. View article details on hiswai:

Excerpt

Jiangsu Recbio Technology Co., Ltd. has received clinical trial approval for R520A, an mRNA COVID-19 vaccine, from the Food and Drug ...

Article found on: community99.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up